Unaudited Condensed Consolidated Statements of Stockholder's Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance at Dec. 31, 2022	$ 620,855	$ 29	$ 946,123	$ (535)	$ (324,762)
Beginning balance (in shares) at Dec. 31, 2022		28,908,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in unrealized gains and losses on available-for-sale investments, net of tax	182			182
Change in unrealized gains and losses on derivatives, net of tax	406			406
Net loss	(9,712)				(9,712)
Stock-based compensation	4,665		4,665
Restricted stock unit withholdings	$ (120)				(120)
Restricted stock unit withholdings (in shares)	(6,000)	(6,000)
Issuance of common stock under stock-based compensation plans	$ 2,286		2,286
Issuance of common stock under stock-based compensation plans (in shares)		154,000
Ending balance at Apr. 02, 2023	618,562	$ 29	953,074	53	(334,594)
Ending balance (in shares) at Apr. 02, 2023		29,056,000
Beginning balance at Dec. 31, 2023	535,495	$ 30	967,651	136	(432,322)
Beginning balance (in shares) at Dec. 31, 2023		29,616,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in unrealized gains and losses on available-for-sale investments, net of tax	(166)			(166)
Change in unrealized gains and losses on derivatives, net of tax	51			51
Net loss	(18,650)				(18,650)
Stock-based compensation	4,544		4,544
Repurchase of common stock	$ (11,444)	$ (1)			(11,443)
Repurchase of common stock (in shares)	(800,000)	(783,000)
Restricted stock unit withholdings	$ (454)				(454)
Restricted stock unit withholdings (in shares)	(32,000)	(32,000)
Issuance of common stock under stock-based compensation plans	$ 1,986		1,986
Issuance of common stock under stock-based compensation plans (in shares)		270,000
Ending balance at Mar. 31, 2024	$ 511,362	$ 29	$ 974,181	$ 21	$ (462,869)
Ending balance (in shares) at Mar. 31, 2024		29,071,000